Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1988; Volume 33,Issue 1
  • You have access
    Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor.
    P W Erhardt, A A Hagedorn and M Sabio
    Molecular Pharmacology January 1988, 33 (1) 1-13;
  • You have access
    Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats.
    S A Knapp, M D Green, T R Tephly and J Baron
    Molecular Pharmacology January 1988, 33 (1) 14-21;
  • You have access
    Primary structures of multiple forms of cytochrome P-450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs.
    R Gasser, M Negishi and R M Philpot
    Molecular Pharmacology January 1988, 33 (1) 22-30;
  • You have access
    Cytochrome P-450 b and c in the rat brain and pituitary gland.
    B M Näslund, H Glaumann, M Warner, J A Gustafsson and T Hansson
    Molecular Pharmacology January 1988, 33 (1) 31-37;
  • You have access
    Synergism between histamine H1- and H2-receptors in the cAMP response in guinea pig brain slices: effects of phorbol esters and calcium.
    M Garbarg and J C Schwartz
    Molecular Pharmacology January 1988, 33 (1) 38-43;
  • You have access
    Histamine receptors coupled to [3H]cAMP accumulation in brain: pharmacological characterization in a vesicular preparation of guinea pig cortex.
    M N Gannon and L B Hough
    Molecular Pharmacology January 1988, 33 (1) 44-50;
  • You have access
    Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
    R M McKernan, W R Strickland and P A Insel
    Molecular Pharmacology January 1988, 33 (1) 51-57;
  • You have access
    Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin.
    W J Morrison and S D Shukla
    Molecular Pharmacology January 1988, 33 (1) 58-63;
  • You have access
    Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.
    H P Too, W G Unger and M R Hanley
    Molecular Pharmacology January 1988, 33 (1) 64-71;
  • You have access
    Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter.
    D Scherman, B Gasnier, P Jaudon and J P Henry
    Molecular Pharmacology January 1988, 33 (1) 72-77;
  • You have access
    Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
    P R Findell, S M Torkelson, J C Craig and R I Weiner
    Molecular Pharmacology January 1988, 33 (1) 78-83;
  • You have access
    Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.
    D W Fry and J A Besserer
    Molecular Pharmacology January 1988, 33 (1) 84-92;
  • You have access
    The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
    G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
    Molecular Pharmacology January 1988, 33 (1) 93-102;
  • You have access
    Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
    J C Stevens and J Halpert
    Molecular Pharmacology January 1988, 33 (1) 103-110;
  • You have access
    Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.
    J G Conway, F C Kauffman, T Tsukuda and R G Thurman
    Molecular Pharmacology January 1988, 33 (1) 111-119;
  • You have access
    Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
    K S Korach, P Sarver, K Chae, J A McLachlan and J D McKinney
    Molecular Pharmacology January 1988, 33 (1) 120-126;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 1
1 Jan 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics